• Even major players in the CBD market do not offer detailed and verifiable study results to effectively differentiate their products on the basis of meaningful clinical findings, essentially exploiting the “natural” label without any R&D efforts
• This industry deficiency represents immense opportunities for R&D-driven companies such as Green Hygienics
• Green Hygienics intends to use its intellectual and capital resources to establish and apply state-of-the-art research and development to a new generation of cannabinoid-based products having specifically assessed health-wellness efficacies

CBD Reality Check  Interest in the therapeutic use of hemp-derived nonintoxicating cannabinoids, such as cannabidiol (“CBD”) and cannabigerol (“CBG”), has reached a fever-pitch in recent years followed by the early-stage preclinical discoveries surrounding the tentative functional role of the endocannabinoid system (“ECS”). CBD received a further popular validation since U.S. FDA approved Epidiolex(R) as adjunctive therapy for pediatric patients with drug-resistant epilepsy. During the last 5-8 years, CBD has been highly acclaimed and heavily hyped. Its medicinal qualities are perceived as limitless by some, and its non-psychoactive nature makes it “suitable” for just about anyone, as it has been claimed by many activists and business entities. The broad-ranging claims of CBD therapeutic utilities are endless, while monopolistic entrepreneurs are rushing the industry in droves, touting first-to-market achievements over quality, research-backed product offerings. Current Status-Quo and Future Expectations  A case can be made that the majority of CBD companies simply ignore the lack of efficacy in their products to avoid potentially undermining their commercial utility, preferring to exploit the “natural” label without any R&D efforts, the very efforts that could establish important evidence-based credibility for their products. Companies marketing products containing CBD have been over-exuberant in their claims about its effectiveness. They have been guilty of illegal, sleight-of-hand, exploiting public enthusiasm over cannabis/hemp by portraying all cannabinoids as not only safe but capable of ameliorating the symptoms of many serious medical conditions. Consequently, the reputation of CBD as a universal “cure-all” puts this still promising substance in the same class as other “natural” panaceas, where anecdotal cases and overwhelmingly biased testimonials supersede the proper efficacy evaluation of already marketed CBD finished products. Notwithstanding, while CBD and other hemp-derived cannabinoids remain a formally unproven therapeutic option with a known mechanism of action, physicians and holistic health/wellness practitioners remain open to the possible future role of these products in the field of alternative management and prophylaxis of different health conditions such as chronic inflammation and pain. Emerging companies like Green Hygienics Holdings (OTCQB: GRYN) have an opportunity to paint a brighter future for the CBD industry and provide a research-based platform for which these physicians and holistic health/wellness practitioners can specifically select and recommend beneficial products meaningful to their intended purpose of providing patient relief. To recommend a particular cannabinoid-based product to patients and wellness-oriented end-users, those practitioners need to adequately analyze specific information and study reports on the experimentally assessed systemic exposure, bioavailability and targeted efficacy of a particular product, instead of focusing solely on the certificate of analysis (“COA”) that verifies only the concentration of bio-active ingredients and absence of harmful contaminants. A very brief survey gathered from the published scientific and commercial papers or conference presentations indicates that even the major players in the CBD market do not possess such study results and reports to differentiate and promote their products based on at least preclinical and/or exploratory clinical study findings. Green Hygienics is Poised to Address the Current State of the Industry On the other hand, this particular status-quo represents the immense opportunities for R&D-driven companies like Green Hygienics in an everchanging cannabinoid market landscape. Physicians and holistic health/wellness practitioners are looking for more advanced, evidence-based cannabinoid products with high, unparalleled, and most importantly unbiased therapeutic efficacies of achievable health-beneficial effects. Green Hygienics is an enterprise that has developed a model resting on this exact premise of bringing evidence-based cannabinoid products to market, backed with unbiased therapeutic efficacies, through research-based evidence. The company aims to be a leader in compliance and capabilities in the hemp and cannabinoid supply marketplace. By leveraging state of the art technologies, the company intends to open up a whole new world of fully characterized novel cannabinoids and targeted bio-delivery technologies never before explored. Green Hygienics is aimed at maximizing the use of intellectual and capital resources. Therefore, the Company has decided to move forward with the establishment of a state-of-art biotechnology R&D facility to focus its resources on the rational and innovative design of formulations, development and experimental evaluation of the new generation cannabinoid-based products with superior bioavailability and specifically assessed health-wellness efficacies. Discovery and development of highly efficacious cannabinoid-based products is a global task that is based on multidisciplinary approaches, collaborations, and partnerships. Therefore, Green Hygienics is building its collaborative platform with several academic institutions, both domestically and abroad, to utilize well established endocannabinoid system (“ECS”) target screening models and develop customized wellness products addressing ECS deficiencies. The ultimate goal is to develop and promote highly functional, experimentally assessed and supported efficacious nutraceutical products that will be trusted by medical communities, physicians, holistic health practitioners, and wellness-oriented end users. For a more in-depth exploration on this topic, please refer to this paper published in Nutritional Outlook by Levan Darjania, PhD. (https://ibn.fm/Sf9eH). About Green Hygienics Holdings Green Hygienics Holdings Inc. (OTCQB: GRYN) is a California-based innovative, technology-driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The company’s corporate mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partner with CPG (consumer packaged goods) and pharmaceutical companies. The company intends to be a leader in compliances and capabilities in the hemp and cannabinoid supply marketplace. Using state-of-the-art technologies, Green Hygienics intends to open a whole new world of novel cannabinoids and targeted bio-delivery technologies never before explored, solving the issues of stability, pharmacokinetics, biological tissue penetration and bioavailability. GRYN is building a team of visionary agrotechnology, pharmaceutical and life scientists working at the intersection of nutraceutical, cosmeceutical and pharmaceutical technologies with a goal to improve lives. View GRYN’s corporate video and follow the company on Facebook, Twitter and Linkedin. Corporate Communications: Heidi Thomasen IR@GreenHygienics.com Toll Free 1.855.802.0299 For more information, visit the company’s website at www.GreenHygienics.com. NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://ibn.fm/GRYN

• Universal desire, worldwide market at heart of the Happy Co.
• The Happy Co. offers functional beverages, capsules, patches, and other products—all carefully designed and formulated to deliver benefits
• Happiness is a lifestyle that the Happy Co. is working to support from every angle

One of the fastest-growing companies in the social-marketing and direct-selling industries, the Happy Co., a subsidiary of Sharing Services Global (OTCQB: SHRG), is building an entire business around happiness. “Happiness is a universal desire,” says the company, which notes that “the world is our market [and] literally every person on earth wants what we offer” (https://ibn.fm/hwP9L). Based on the ideal that everyone deserves to be happy, the Happy Co. has created a business model to make happiness happen for everyone involved with the company. The Happy Co. offers functional beverages, capsules, patches, and other products—all carefully designed and formulated to elevate mood, boost energy, reduce stress, enhance sleep, help with weight management, and make consumers look and feel happier. While the company’s focus on making happiness happen starts with exclusive, extraordinary products, that is only the beginning. Happiness is a lifestyle, one that the Happy Co. is working to support from every angle. From the first sip of morning coffee, this social-marketing innovator is looking for every opportunity throughout the day to harness the power of happiness. The Happy Co. offers its community members products and opportunities designed to surprise and delight—and instill happiness. The Happy Co. is the new brand identity of SHRG’s wholly owned subsidiaries Elevacity Holdings LLC and Elevacity U.S. LLC. (https://ibn.fm/xX6QJ). The rebranding involved a complete rehaul of both the consumer-facing website, which was created to be the place where customers purchase Happy Co. products, and the business website, which is designed to be the hub showcasing the business opportunity. “The Happy Co. is not just a name; it is the best descriptor of our mission,” said Bo Short, CEO of Elevacity Holdings LLC and Elevacity International Holdings LLC. “It directly mirrors our values and purpose of sharing happiness through products and experiences that elevate lives. Our brand partners and our customers live this experience every day. This new branding is an important step as we begin our global expansion in 2021. It connects perfectly to our enhanced business platform and ever-growing ecosystem of products.” The new branding is launched as an integral part of Sharing Services’ efforts to accelerate growth in the international landscape. Designed to emanate a pleasant feeling, the branding works hand in hand with the company’s offering developed to fuel customers for the good life. With the Happy Co. branding firmly in place, SHRG is proving again that it is a quick mover that adjusts effectively to emerging market demand as studies show that health awareness and community are key building blocks of new consumer behavior. For more information, visit www.SHRGInc.com and www.TheHappyCo.com. NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

• Brokerage firm H.C. Wainwright & Co. recently released report featuring UEC, reiterates Buy rating
• Recent drilling activities at UEC’s Burke Hollow in situ recovery (“ISR”) project show strong results, potential for further resource growth
• UEC well-financed to aggressively pursue key developmental targets, the Company has over $110 million in cash, equity and inventory holdings
• UEC is production ready with four fully licensed uranium projects and a state-of-the-art Central Processing plant with a combined production profile of 4 million pounds of uranium per year

Uranium Energy (NYSE American: UEC), a Corpus Christi, Texas-based uranium mining and exploration company, was recently featured in an H.C. Wainwright & Co. (Wainwright) equity research report that covered wellfield development, resource delineation and company financial updates (https://ibn.fm/rhR2m). Wainwright analysts reiterated their Buy rating for UEC’s stock based on a discounted cash flow (“DCF”) model of future operations and in situ asset values

“We are reiterating our Buy rating on UEC and our PT of $5,” reads the research report. “Our valuation remains based on a DCF of future operations for the firm, utilizing our recently revised 7.5% discount rate. We then add an in situ value of $75.0M for UEC’s Reno Creek assets, $41.5M for Alto Parana’s resources, and an additional $40.0M for Paraguay and UEC’s other exploration stage assets. We continue to believe that these figures remain inline with similar projects throughout our coverage universe to which we assign equal geopolitical risk factors.”

Wainwright backs its recommendation by UEC’s recent drilling activities at its Burke Hollow ISR project in South Texas, where strong results demonstrated promising growth potential (https://ibn.fm/avrBj). Wainwright also detailed the closure of UEC’s recent offering that grossed $12 million, with expectations that the net proceeds will be applied towards additional uranium purchases and general working capital requirements. Accordingly, the report states that UEC’s total cash, equity, and inventory holdings of $110 million can fully fund its physical uranium initiative that stands at 2.105 million pounds at a weighted average price of about $30 per pound, with deliveries expected between March 2021 and December 2022.

Favorable market predictions in the Wainwright report include growth in global demand, increased domestic demand from the U.S. Uranium Reserve, and long-term rising uranium prices that may drive positive production decisions at one or more of UEC’s projects.

Founded in 2003, Uranium Energy Corp. is a U.S.-based uranium mining and exploration company that controls one of the country’s largest historical uranium exploration and development databases. By leveraging historical exploration data, UEC has been able to target and acquire properties that have already been subject to exploration and development by senior energy firms in the past, positioning it favorably to capitalize on rising global uranium demand while using green technology that favors the environment. The Company has a near term extraction profile of 4 million pounds of U3O8 per year from its low-cost South Texas and Wyoming ISR projects.  With the largest U.S. resource base of fully permitted and environmentally friendly ISR projects in Texas and Wyoming, UEC is ideally positioned to be the leader in a resurgence of domestic uranium mining.

For more information, visit the company’s website at www.UraniumEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC

• PlantX Life launches new refrigerated and frozen food product lines as consumers seek healthier and sustainable food options amid the pandemic
• PLTXF has also switched to green packaging, which marks the first part of its newly launched sustainability initiative
• PLTXF appears poised for long-term growth as studies show the shift in consumer trend is here to stay

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) is set to thrive as consumers change habits amid the pandemic. As a marketplace providing consumers all things plant-based, the company has launched a new refrigerated and frozen food product line to capitalize on the current market environment where consumers increasingly turn to healthier and sustainable lifestyle choices. The pandemic has revealed that consumers changed the way they think about, purchase and consume their food, placing a much bigger emphasis on sustainability and health (https://ibn.fm/km4yj). Committed to early recognition of emerging market trends, PlantX Life was quick to adjust to these newly surfacing consumer trends. The company has recently launched a refrigerated and frozen food segment that offers high-quality fresh and frozen plant-based food products delivered at consumers’ door. The plant-based food industry was on the rise even before the pandemic, but the virus outbreak has propelled the sector to new heights. The new product addition provides convenient, yet premium plant-based food products targeted at consumers who value both comfort and wholesomeness when it comes to food. The plant-based brands represented include Beyond Meat, Impossible Foods, Miyokos, Follow Your Heart, Gardein, Tofurkey and Alpha Foods. The new products are now available in the ‘Frozen’ and ‘Refrigerated’ sections of the company’s United States e-commerce platform. The frozen section offers a wide selection of frozen food across multiple product categories such as appetizers, bread & dough, desserts, entrees & sides, fruit, meat alternatives, pizza and vegetables (https://ibn.fm/CVmZD). Refrigerated food assortments include beverages, bread, condiments & dressings, dairy & egg alternatives, dips and meat alternatives (https://ibn.fm/d6puM). With the addition of frozen and refrigerated items, PlantX Life will be able to provide a broad offering of products as a one-stop-shop for everything plant-based e-commerce platform. The newly added products will be available for shipping to Canadian customers later this year. Also available in the brick-and-mortar stores, these products offer consumers nutritious-rich fresh and frozen food selection across a range of specialized diets — from gluten-free, non-GMO, organic, soy-free, paleo-friendly, to keto-friendly, kosher, nut-free, allergen-free and sugar-free. Committed to promoting both the health of people and nature, PlantX Life now uses sustainable packaging to minimize the environmental impact of packaging waste of its products. The company partnered with Quebec-based company Colder Fresher Longer to introduce new packaging standards that will allow it to reduce the carbon footprint. This move marks just the beginning of PlantX’s plans to adopt broader sustainability practices as eco-friendly and ethical considerations have become an essential purchasing consideration for the modern consumer. The shift in consumer behavior favoring healthy and sustainable choices is not only widespread but most likely permanent. The overwhelming majority (75%) of consumers plan to eat and drink healthier due to the pandemic (https://ibn.fm/AHphO) and the change has become more pronounced one year later (https://ibn.fm/tQ1Hv). This indicates a fundamental, long-term shift in consumers’ attitudes toward health and wellness. The company’s business model based on the combination of e-commerce and health-focused plant-based food products appear to be a winning match for the current market environment and beyond. For more information, visit the company’s website at www.Investor.PlantX.com, and view PlantX for Plant-Based Investors. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

• Fan Pass creates the streaming space for artists to gain revenue, go live, and build their fanbase
• Friendable is currently in the beta phase version 2 for the mobile and desk application of the Fan Pass platform, which will feature a new design, technology advancements, backstage VIP access, and scalable social media
• The updated version is expected to become available as early as June 2021
• The global music streaming market is expected to grow exponentially, from $20.9 billion in 2019 to $76.9 billion by 2027

Friendable (OTC: FDBL) announced another record month of growth for its Fan Pass platform, which reported 1,236% of live artist channel growth over March 2021. The increase comes as the company announced that it has entered beta phase version 2 of the Fan Pass mobile and desktop application, featuring an all-new design, technological advancements, backstage VIP access, and scalable social media. These enhancements will benefit both the fans and the artists who use the platform (https://ibn.fm/qRZc8). At the end of March 2021, 22 live artist channels across various musical genres were completed on the Fan Pass platform. With the number of live performances doubling from the month prior, April was the month that Friendable had expected a significant ramp-up of new live artist channel activation on Fan Pass. The success of the deployed technology and dashboard upgrades have allowed the company to use some of these new features to advance live channels before fully releasing version 2 of the platform. Friendable anticipates that version 2 will be available in early June 2021. “With entirely new and updated technologies, UI, UX designs, and general interactions and enhancements made on the platform, our team is extremely excited about rolling out version 2 of Fan Pass to our current artists, new artists, and their fans,” CEO Robert A. Rositano said. Since its launch in July 2020, Fan Pass has been growing steadily, positioning itself as a unique avenue for enhanced interaction and engagement between artists and fans in a fully safe, online environment. Always committed to service artists and fans, the team behind Fan Pass has been gathering user feedback about the platform and hopes version 2 will address all issues while exceeding collective expectations. Fan Pass was designed to give artists a virtual stage, allowing them to earn money while increasing their fan base. The new v2 enhancements will allow for quicker artist onboarding and better navigation of the platform. Artists get to: Create New Revenue

• Artists get paid for live or PPV events
• 100% of ticket sales go to the artist (less any fees for an agency, agent, manager, etc. if applicable)
• Gain a share of the monthly subscription revenue based on “content views” generated by all Fan Pass fans across the platform

Build a Fanbase

• Artists upload content to the platform, keeping their fans engaged
• Fan Pass has all the promotions that an artist could need – merchandising, marketing, etc.

Go Live – with Livestreaming

• Artists sell tickets to live performances and events streamed in the highest quality available right to the fans’ phone or computer – all an artist has to do is notify they are going live, and fans stay in the loop!

Fan Pass also offers a Pro Services option, which covers everything from graphic design to marketing to merchandising. Services start at $90 (currently $45 with the promotional pricing) for a Basic Marketing Materials Package and increase to $1000 (currently $500 with the promotional pricing) for the customized Merch Collection. Fan Pass Pro Services is one of the many perks that artists joining the platform have access to. With its livestreaming services and options, Friendable is well positioned to become a top platform of choice for musicians and fans alike due to the opportunities for continued engagement and revenue generation, earning Fan Pass a prominent role in the fast-growing global music streaming market. In 2019, before the pandemic, the music streaming sector was valued at $20.9 billion, but it expected to expand at a CAGR of 17.8 percent and reach $76.9 billion by 2027, amid growing interest in music streaming services (https://ibn.fm/3YTiV). For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• The name Sonoma is analogous with not only wine country but diversified agriculture, and now ultra-premium cannabis
• High-end consumers are seeking out place-based designations that they trust and they willing to pay a premium
• Investors are turning to companies like Sonoma Biologics, who have already established themselves within the competitive California market and have shown themselves capable of scaling up quickly without compromising on product

Sonoma Biologics, an ultra-premium cannabis grower focused on the medicinal and recreational cannabis markets, is on a mission to become one of the largest organic-equivalent, environmentally friendly cannabis suppliers in northern California. The Company utilizes solar energy and is on the path to becoming a certified comparable-to-organic cannabis grower through the OCal program, a statewide certification comparable to the National Organic Program. While California growers are scrambling to keep up with the trends of 2021, Sonoma Biologics has already established itself (https://ibn.fm/Hvsp7). “We see cannabis being grown in wine country the same way we see Napa and Sonoma grapes being accepted all over the world,” says Paul Caracciolo, Sonoma’s CEO & Co-Founder. “The name Sonoma to me is analogous, not only with wine country, but also with broad diversified agriculture.” The area is already well known for its exquisite vineyards and the wine they produce. Sonoma county has also established itself as a leader in organic produce and sustainable farming.  High-end and organic-conscious consumers seek out place-based designations for their products in the same way that wine connoisseurs turn to Sonoma for the highest quality of wine. Anticipating price fluctuation in the market, evolving taxes and difficulty with quality compliance and California regulations, turnover of cannabis businesses is expected in Q3 of 2021 and on. Investors are turning to companies that have already established themselves within the competitive market and have shown themselves capable of scaling up quickly without compromising on product. Consumers in 2021 are seeking out products that are naturally sun-grown, as opposed to greenhouse and warehouse growth. They are seeking out place-based designations that hold quality certifications. Currently, consumers are willing to pay premium for these products, and California is working to formalize appellations. “Participating in the CDFA, the California Department of Food and Agriculture, will ensure that customers who see the Sonoma designation on a product label, will instantly understand they are getting the highest quality, sun-grown, natural, pure product,” says Caracciolo (https://ibn.fm/CwoxV). The team at Sonoma Biologics strongly believes that sun-grown cannabis has different concentrations of terpenes and qualities you won’t find in products grown indoors under artificial light. With multiple outdoor growing locations situated in the heart of California’s wine country, the Company is capable of large-scale, ultra-low-cost production. Management has been in the large-scale agriculture business for the last decade in Sonoma and entered into cannabis in the previous three years. Having passed stringent California quality control regulations for cannabis since beginning, they continue to provide a high-quality, sun-grown, natural, sustainable, pure, and consistent product. “Our approach is being consistent and finding things that work and sticking to them,” says Caracciolo. “If you look across the crop that we have, all the plants are exactly the same size. It’s the way that you treat them, it’s the spacing, it’s the nutrition you give them.” For more information, visit the company’s website at www.OwnSonomaBiologics.com. NOTE TO INVESTORS: The latest news and updates relating to Sonoma are available in the company’s newsroom at https://ibn.fm/Sonoma

• Catalog features musical tracks from A-list celebrity musical artists including Beyonce, Justin Timberlake, Demi Lovato, Cher, and more
• NFTs are hosted on Ethereum blockchain with potential trading on OpenSea
• Three royalty pools available for staking: publishing, mechanical/public performance, and synchronization, and tokens will be available in addition to these pools
• Stakers have the opportunity to earn four different ways with the BAND NFTs, but royalties are not a guarantee
• The market has exploded coming into 2021 due to the increased exposure of NFTs, especially after Twitter CEO Jack Dorsey’s sale of his first tweet for $2.9 million

Operated by Singapore-based LIBERTY IS PTE LTD, BAND Royalty is an entertainment technology-driven firm focused on distributing non-fungible tokens (“NFTs”) that allow fans to earn royalties from top songs and artists worldwide. Fans get to take their enjoyment of music to the next level through BAND Royalty NFTs that enable holders to earn crypto from some of the world’s most popular songs. The unique opportunity allows individuals to share income streams each time a song in the NFT catalog is performed. The pool of BAND’s NFTs leverage a performance catalog that features musical tracks from A-list musicians, including Beyonce, Justin Timberlake, Demi Lovato, Cher, and more, earning royalties every time the catalog is played (https://ibn.fm/hfYT8). The NFTs are hosted on the Ethereum blockchain, with owners of the NFTs being able to trade them on one of the largest NFT marketplaces – OpenSea. The revenue generated from the BAND music royalty catalog is not guaranteed, much like revenues for market investments cannot be guaranteed. Stakes in the three BAND music royalty pools can range from 90 days to five years once the smart contracts open up at the beginning of Q3 in July 2021. All holders of BAND NFTs during Q2 will automatically qualify for royalty payments in Q2, provided that they stake immediately upon the opening of the royalty pool smart contract. The royalty pools available for staking include 1) publishing, 2) mechanical/public performance, and 3) synchronization. A share in the royalty pools is only available for those who stake BAND NFTs, and staking does not equal ownership of royalties but provides access to income from the various royalty streams. BAND NFT stakers earn four ways:

1. Earning 50% from all BAND Royalty music catalog revenue.
2. Earning 5% on BAND NFTs traded on OpenSea or the BAND platform.
3. Earning 50% from any auctions of single BAND music tracks sold.
4. Earning 5% from reselling music royalties on the band platform.

BAND Royalty plans on four limited-edition NFT series that will include 3,000 NFTs plus a standard fungible BAND token and BAND app. BAND will issue a total of up to 12,000 NFTs, designed to be stand-alone collector items that provide collectible value – something not seen in other NFTs to date. The first limited-edition NFTs will be launched on May 5, ,2021, followed by the second NFT series in June and a third in August, with various events occurring concurrently. The market for NFTs has taken off exponentially in 2021 due to a rise in media coverage and mainstream awareness. An example of a recent NFT is the first tweet ever sent by Jack Dorsey, the CEO of Twitter and Square. Dorsey sold this tweet as an NFT for over $2.9 million in March 2021 (https://ibn.fm/avJGF). Other instances of higher-profile NFT sales include the “Everyday: The First 5000 Days”, a digital art piece by artist Beeple that sold for $69.3 million at Christie’s, and a music video by digital artist Slime Sunday and 3LAU that sold for $1.3 million, with the buyer winning the opportunity to name the song (https://ibn.fm/Z8Qte). Founded by Barnaby Andersun (“BA”) and Noble Drakoln (“ND”), who leverage years of experience in blockchain, e-commerce, and music royalties, BAND Royalty is uniquely positioned to capitalize on the shifting landscape surrounding digital ownership as it launches its NFT offering. For more information, visit the company’s website at www.BANDRoyalty.com. NOTE TO INVESTORS: The latest news and updates relating to BAND Royalty are available in the company’s newsroom at https://ibn.fm/BAND

• XPhyto Therapeutics Corp. recently announced it has entered into a distribution, storage and logistics agreement with a German distributor with an established network throughout Germany
• Germany holds promise due to regulations requiring mandatory weekly testing for its citizens; this has the possibility of ramping up sales
• Anticipating the increase in sales and distribution, XPhyto expanded its commercial leadership team by bringing on board Mr. Wolfgang Probst and Mr. Manfred Buchberger
• Mr. Probst will be the company’s Chief Operations Officer (“COO”), while Mr. Buchberger will be the Head of Corporate Development at wholly owned subsidiary XP Diagnostics GmbH

The approvals XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) received in Europe back in March for the commercial production and use of its commercial 25-minute COVID-19 RT-PCR test system (“Covid-ID Lab”) (https://ibn.fm/VwPeW), set the ball rolling for events that would lead to a recent announcement. On April 21, XPhyto, a life sciences technology accelerator, announced it has entered into a distribution, storage and logistics agreement with a full-fledged German pharmaceutical wholesaler and service provider, which will back the company’s efforts to launch sales in April (https://ibn.fm/65aYL). The German distributor will distribute, store, and deliver the Covid-ID Lab test kits to XPhyto’s customers in line with the relevant logistical and regulatory requirements in Germany and the product specifications. In addition, the agreement stipulates that the distributor fulfills storage, reporting and notification obligations, processes any product returned by buyers and provides documentation. With the agreement, XPhyto CEO and Director Hugh Rogers noted that the company had secured a strong partner with an already established network in Germany. “The company’s commercialization strategy is focused on the German market for initial product launch and the creation of robust and sustainable sales,” he added. Germany shows promise as a market that will ramp up XPhyto’s sales revenue. The slowed vaccination rollout in the country has meant that testing requirements have persisted. In fact, in late March, the government made it mandatory for workers employed in sectors where physical contact with customers is inevitable to take at least two rapid tests weekly (https://ibn.fm/EWjuk). The new regulations also mandated every person to conduct a point-of-care test before attending a private or public event (https://ibn.fm/cTE6B). These regulatory changes came barely a month since the country experienced shortages in rapid test kits following a steep spike in demand during the first week of March. This rise in demand was occasioned by the German government’s reliance on rapid tests to steer the country through the pandemic and assuage the citizens’ displeasure at the prevailing COVID-19 lockdowns at the time. Beginning the second week of March, every German citizen would be entitled to a single free rapid test every week, to be conducted by a professional at designated testing centers or pharmacies (https://ibn.fm/uYHtJ). Combined, these regulatory requirements show that the conditions are favorable for XPhyto to witness sustainable sales, particularly with the inking of the distribution deal. Anticipating this rise in sales, the company made additions to its leadership team, focusing on the commercial aspect of the business (https://ibn.fm/9UuBL). In a recent announcement, XPhyto reported that it had appointed Mr. Wolfgang Probst as its Chief Operations Officer (“COO”) and Mr. Manfred Buchberger as the Head of Corporate Development at XP Diagnostics GmbH, XPhyto’s wholly owned German subsidiary. Both Mr. Probst and Mr. Buchberger bring a wealth of experience to their new positions. Mr. Probst, a seasoned management and finance consultant with a proven track record of organizational restructuring, strategic planning and leadership, is credited with restructuring XPhyto’s operations in Europe, as well as spearheading partnerships with institutions and other companies. He will be in charge of the company’s global operations and remain the XP Diagnostics MD and an XPhyto director. Mr. Buchberger, a global leader in the medical diagnostics industry, has near ten years’ experience as a CEO and member of the Global Management Board of a leading medical diagnostics and analytics company based in Europe. He is accredited with launching new medical diagnostic products, as well as creating, effecting and managing business growth strategies across four continents. For more information, visit the company’s website at www.XPhyto.com. NOTE TO INVESTORS: The latest news and updates relating to XPHYF are available in the company’s newsroom at https://ibn.fm/XPHYF

• Retail chain store projected to generate estimated $10M annually
• Company CEO calls acquisition “transformative”
• Retail is valued resource for GLH development of product lines, execution on brand messaging

Golden Leaf Holdings (CSE: GLH) (OTCQB: GLDFF), a proven, consumer-driven cannabis company in both the medicinal and recreational marijuana market segments, has signed a letter of intent (“LOI”) to acquire a retail chain in Northwest Oregon, which is forecast to generate an estimated $10 million in annual run rate revenue (https://ibn.fm/dRY8o). “The acquisition of this retail chain will be transformative for GLH, as it would further cement us as a leader in the Oregon market,” said Golden Leaf CEO Jeff Yapp. “The company expects this transaction to be accretive on close, as we will achieve tremendous synergy with our effort and current footprint and the introduction of our market-leading Chalice brand products.” Golden Leaf plans on providing additional details about the transaction once a definitive purchase agreement has been completed. The strategic move aligns with Golden Leaf’s focus on retail, which the company feels is a dynamic and effective tool to truly understand the current state of the marketplace. Golden Leaf looks to its seven Chalice Farms retail stores located throughout the Portland area as invaluable resources for instant customer feedback. “Our retail stores provide a daily report as to what products are working best and what needs improvement,” the company states. “[Retail] gives us first-hand information about what’s trending in the market and what people are asking for. Retail is a valued resource for our development of product lines and executing on brand messaging.” From the opening of its first Chalice Farms dispensary, the company has been committed to creating a different experience for consumers. Each location is inviting and warm, with an approach similar to the Apple store model, with products featured on island stations located throughout the store. The design is intended to invite interaction and connection between Chalice Farms personnel and consumers, creating an open atmosphere where questions can be asked, information can be exchanged, and a positive experience will be enjoyed. Key to that positive experience are Chalice Farms product specialists, who are highly trained in all the products offered at each retail location. Golden Leaf provides ongoing training and education to ensure these friendly company representatives have information necessary to assist a broad range of consumers, from the first-time visitors to the high-end connoisseurs. With a wide array of products that are often updated, informed product specialists are essential to the five-star consumer experience that Golden Leaf is committed to provide. For more information, visit the company’s website at www.GoldenLeafHoldings.com. NOTE TO INVESTORS: The latest news and updates relating to GLDFF are available in the company’s newsroom at https://ibn.fm/GLDFF

• Definition of craft spirits differs widely from distillery to consumer
• SBEV’s SALT Tequila strives to stand out among tequila crowd
• SALT Naturally Flavored Tequila is 100% Blue Agave, 80 proof
• Careful attention to detail results in mellow, sweet, fully developed agave flavor unmatched in industry

The definition of craft distillery varies throughout the industry; in fact, the American Craft Spirits Association (“ACSA”) has decided not to define craft but allow its members and consumers to ultimately determine their own definition (https://ibn.fm/iKQzn). Splash Beverage Group (OTCQB: SBEV), a holding company of leading portfolio of beverage brands, has defined the term with its one-of-a-kind SALT Tequila (https://ibn.fm/2Mk1J). Although the ACSA accepts that the term “craft” is in the eye of the beholder, the association notes that it thinks of craft spirits as “a product produced by a distillery who values the importance of transparency in distilling, and remains forthcoming regarding the spirit’s ingredients, distilling location, and aging and bottling process.” Splash Beverages does all of this and more through the creation of its proprietary SALT Tequila. Splash notes that its unique tequila offering relies on the focus and dedication of a boutique distillery, the skill and expertise of a tequila master, and experts trained in the art and craft of tequila. The result? The first and only tequila crafted to be enjoyed as a drink—best neat or over ice. And no wonder the beverage stands out in the tequila crowd. Each bottle of SALT Tequila is made from handpicked, 100% pure blue agave plants grown in the mountains of Jalisco. The area is one of the Mexico’s most fertile agave-growing regions, and each agave plant grows seven to 10 years before being harvested. Such attention to detail results in a mellow, sweet, fully developed agave flavor unmatched in the industry. In short, SBEV’s SALT Tequila represents years of deliberate determination, inspiring innovation, and invaluable expertise culminating together in the clear, smooth, sweet and natural flavor that has come to define one of the industry’s finest tequila offerings. Specializing in manufacturing, distributing, sales and marketing of various beverages across multiple channels, Splash operates in both the alcoholic and nonalcoholic beverage segments, allowing it to leverage efficiencies and dilute risk. The company’s business strategy is to quickly develop and accelerate pre-existing brands to exit for cash events. The company’s management team has invaluable expertise and insight, and the company strives to identify brands it perceives to have highly visible preexisting brand awareness or pure category innovation. Specifically, the company look for brands and products that are on trend and deliver natural quality, health benefits, freshness and refreshment within their beverages. The company looks to maintain highest performance standards and focus on execution as it works with distributors and retail partners to achieve and exceed all goals. In addition, the company offers support for members of the U.S. armed forces, first responders and health-care professionals. For more information, visit the company’s website at www.SplashBeverageGroup.com. NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV